Purchase Order 75N92E24P00125
Award Date
4/8/24
Potential Completion Date
5/7/24
Potential Value
$12K
Federal Agency
National Human Genome Research Institute
Ultimate Awardee
Not listed
NAICS Category
541713 - Research and Development in Nanotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Human Genome Research Institute (NHGRI), a civilian agency, awarded a $23,590.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the supply of 3 packs of 4 PromethION flow cell packs (RNA) with a period of performance through December 31, 2024. This award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contract awards from agencies such as the National...
This federal contract award was made by the National Institute on Aging (NIA), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $232,150.00 firm fixed-price purchase order is for the delivery of PROMETHION FLOW CELL PACKS, a product related to Oxford Nanopore's PromethION sequencing platform. The contract has an ultimate completion date of May 1, 2028 and was awarded on May 2, 2025. While the contract does not have a set-aside...
This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
This firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization. The $10,928.00 award is for the delivery of Oxford Nanopore's DNA sequencing flow cells and reagents to support long-read sequencing activities at the agency's DNA Sequencing Core. The contract has a completion date of November 7, 2023 and does not utilize any...
The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,508.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of 3 packs of 4 PROMETHION flow cell packs (RNA), with an ultimate completion date of August 7, 2024. This equipment supports NHGRI's ongoing genomics research initiatives, which utilize Oxford...
This federal contract award, valued at $22,600, was issued by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the procurement of SCIENTIFIC EQUIPMENT - PROMETHION FLOW CELLS, with a completion date of Nov 15, 2024. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for analyzing single molecules, including DNA, RNA,...
This federal contract award, valued at $75,200.00, was issued by the National Institute on Aging (NIA), a civilian agency under the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the delivery of PromethION Flow Cell Packs (R10.4.1) for an ongoing NIA research project. The contract is a firm-fixed-price purchase order with a completion date of September 14, 2024. The original sources sought notice...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was made by the National Institute for Minority Health and Health Disparities, a civilian agency. The $16,500.00 firm fixed-price purchase order is for the delivery of OXFORD NANOPORE TECHNOLOGIES, INC.; FLOW CELL R9 4.1 products by December 31, 2023. This contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the delivery of RNA sequencing kits, ligation sequencing kits, rapid barcoding kits, and flow cells. The $70,000.00 firm-fixed-price purchase order was awarded by the Southeast Area office of a civilian federal agency. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts to provide...
This federal contract award, with ID AG4216P170059, was made by the U.S. government's Southeast Area agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $79,026.00 firm fixed-price purchase order is for the delivery of flow cells and sequencing kits. The award does not have a set-aside designation. Through this contract, Oxford Nanopore Technologies is supplying next-generation genomic sequencing equipment, consumables, and associated services to...